Spinel Karas, PharmD, PhD (she/her/hers)

Clinical Pharmacologist
Pfizer Inc

Poster(s):

• (M-012) Population pharmacokinetics and pharmacodynamics analysis of PF-07328948, a branched-chain ketoacid dehydrogenase kinase inhibitor, in healthy participants
  Monday, October 20, 2025

  7:00 AM - 5:00 PM MDT